リーシュマニア症治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00008181
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Leishmaniasis Treatment Market Insights and Growth by 2031

Buy Now

市場紹介

リーシュマニア症は、感染した雌のサシバエに刺されることによって広がるリーシュマニア原虫の感染によって引き起こされます。リーシュマニア症の臨床範囲は、自然に治癒する皮膚潰瘍から疾患、さらには致命的な全身疾患に至るまで多岐にわたります。

市場ダイナミクス

リーシュマニア症の治療市場は、この病気を治療するための科学技術の継続的な研究開発により、製薬会社や組織が新しい方法や治療法を採用する可能性が高いため、成長すると予想されています。さらに、満たされていない医療ニーズは、すべての研究開発プログラムにとって、世界のリーシュマニア症治療薬市場に投資する機会をもたらすと推定されています。

市場範囲

「2031 年までのリーシュマニア症治療市場分析」は、世界市場の傾向分析に特に焦点を当てたヘルスケア業界の専門的で詳細な調査です。このレポートは、疾患の種類、病理学的検査、治療の種類、エンドユーザー、地域ごとに詳細な市場分割を行い、リーシュマニア症治療市場の概要を提供することを目的としています。リーシュマニア症治療市場は、予測期間中に高い成長を遂げると予想されます。このレポートは、リーシュマニア症治療市場の主要企業の市場状況に関する重要な統計を提供し、市場の主要な傾向と機会を提供します。

市場セグメンテーション

リーシュマニア症治療市場は、疾患の種類、病理検査、治療の種類、エンドユーザーに基づいて分割されています。疾患の種類に基づいて、市場は皮膚リーシュマニア症、粘膜リーシュマニア症、内臓リーシュマニア症に分類されます。さらに、皮膚リーシュマニア症に基づいて、市場はびまん性皮膚リーシュマニア症と皮膚粘膜リーシュマニア症に分類されます。病理学的検査に基づいて、市場は血清学的検査、寄生虫学的評価、DNA ベースの方法、免疫学的方法などに分類されます。治療の種類に基づいて、市場は薬物療法と非薬物療法に分類されます。さらに薬物療法に基づいて、市場は五価アンチモン薬、抗真菌薬、抗生物質に分類されます。さらに非薬物療法に基づいて、市場は焼灼、外科的切除、凍結療法に分類されます。

地域フレームワーク

このレポートは、定性的情報と定量的情報の両方を含む業界の詳細な概要を提供します。さまざまなセグメントに基づいて、リーシュマニア症治療市場の概要と予測を提供します。また、次の 5 つの主要地域に関して、2021 年から 2031 年までの市場規模と予測推定値も提供します。北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、南および南。中米。各地域ごとのリーシュマニア症治療市場は、その後、それぞれの国とセグメントごとにサブセグメント化されます。このレポートでは、世界 18 か国の分析と予測、およびこの地域に広がっている現在の傾向と機会について取り上げています。

レポートは、需要側と供給側の両方からリーシュマニア症治療市場に影響を与える要因を分析し、予測期間中に市場に影響を与える市場のダイナミクス、つまり推進力、制約、機会、将来の傾向をさらに評価します。このレポートは、5 つの地域すべてに対する徹底的な PEST 分析も提供します。北米、ヨーロッパ、APAC、MEA、南および南。中米では、これらの地域のリーシュマニア症治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。


市場参加者

このレポートでは、有機的および無機的な成長戦略として、リーシュマニア症治療市場の主要な発展について取り上げています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で目撃された無機質な成長戦略は、買収、パートナーシップ、および企業の買収でした。コラボレーション。これらの活動により、市場プレーヤーのビジネスと顧客ベースの拡大への道が開かれました。リーシュマニア症治療市場の市場プレーヤーは、世界市場でのリーシュマニア症治療市場の需要の高まりに伴い、将来的に有利な成長の機会があると予想されています。以下は、リーシュマニア症治療市場に携わる数社のリストです。

レポートには、SWOT分析と市場戦略とともに、リーシュマニア症治療市場の主要企業のプロフィールも含まれています。さらに、このレポートは業界の主要企業に焦点を当てており、会社概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、過去 5 年間の主な開発などの情報を提供します。

     アッヴィ株式会社 Enzon Pharmaceuticals (Abelcet)  ;ギリアド ライフ サイエンス Gland Pharma LimitedGlaxoSmithKline plc. Informa plc. Lifecare Innovations Private Limited Paladin Labs Inc.、 Sanofi SA Sequus Pharmaceuticals Inc.

Insight Partner の専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、既存の調査にさまざまなカスタマイズ オプションを提供します。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. AbbVie Inc.
2. Enzon Pharmaceuticals (Abelcet)
3. Gilead Life sciences
4. Gland Pharma Limited
5. GlaxoSmithKline plc.
6. Informa plc.
7. Lifecare Innovations Private Limited
8. Paladin Labs Inc.,
9. Sanofi S.A
10. Sequus Pharmaceuticals Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Pharmaceuticals : READ MORE..